miR-124 Modulation for Stem Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating glucose-sensing and insulin-secreting β-cells from human embryonic stem cells are time-consuming and complex, posing challenges for the treatment of type 1 diabetes.
Innovation Solution
Isolation of mammalian pancreatic progenitor cells that express insulin, betatrophin protein or betatrophin mRNA, and C-peptide, with elevated miR-124 expression, achieved through modulating miR-124 in mammalian trophoblast stem cells using agents like bFGF, 2-mercaptoethanol, and nicotinamide to induce differentiation into insulin-producing cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current hES cell approaches are used to generate β-cells, then glucose-sensing and insulin-secreting β-cells can be generated, but the process is time-consuming and complex
Solution Approach 1:
The patent applies preliminary action by pre-establishing the miR-124 modulation strategy and agent combination before actual differentiation begins. The miR-124 mimic or inhibitor is introduced at specific time points (e.g., day 0, day 1, or day 2 of differentiation) to pre-program the differentiation pathway, thereby accelerating the overall process while maintaining reliability of β-cell generation.
Solution Approach 2:
The patent employs parameter changes by modifying the miR-124 expression level (either upregulating with mimics or downregulating with inhibitors) to control the differentiation kinetics. This molecular parameter modulation enables faster and more efficient differentiation compared to conventional hES cell approaches, directly addressing the time loss issue while preserving the functional characteristics of generated β-cells.
2Reliability
If current hES cell approaches are used to generate β-cells, then glucose-sensing and insulin-secreting β-cells can be generated, but the process is complex
Solution Approach 1:
The patent extracts the essential control mechanism from the complex differentiation protocol by identifying miR-124 as the key regulatory molecule. By focusing on this single critical parameter and using specific agents (miR-124 mimics or inhibitors) that directly modulate it, the protocol simplifies the differentiation process while maintaining reliable β-cell generation, effectively removing unnecessary complexity.
Solution Approach 2:
The patent introduces miR-124 as an intermediary molecular switch that mediates the differentiation process. By using miR-124 mimics or inhibitors as intermediary agents, the complex differentiation pathway is simplified into a more manageable process controlled by a single molecular mechanism, reducing protocol complexity while preserving functional outcomes.
3Productivity
If miR-124 is modulated to induce differentiation, then differentiation efficiency is improved, but control over differentiation timing and stage becomes critical
Solution Approach 1:
The patent applies periodic action by introducing miR-124 modulation at specific time intervals during the differentiation process. The miR-124 mimic or inhibitor is added at defined time points (e.g., day 0, day 1, or day 2) and maintained for specific durations, creating a periodic treatment schedule that enhances differentiation efficiency while providing clear temporal control over the differentiation stages, making the process easier to operate and reproduce.
Data Source
Figure 1A
Figure 1B
Figure 1C
AI summary
Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.